(S6O-05494) The performance for the 31-day standard is 95.1 per cent, which is above the 95 per cent target, with the median wait for treatment being just two days.We are investing £14.24 million of the £137 million of planned care funding that was made available in 2025-26 directly in efforts to reduce cancer waiting times, supported by increasing radiology capacity to support seven-day working, and by publishing and implementing optimal diagnostic pathways for lung, head and neck and colorectal cancers, with a total of almost £7.5 million of investment to ensure that patients have cancer ruled in or out faster. We have also established the six rapid...